14 Jan A Life-Saving Supreme Court Decision
Late on Tuesday this week, the Supreme Court reached an unexpected decision.
The Justices reinstated requirements that women seeking medication abortions receive the drugs in person at a clinic, setting aside a judge’s ruling that this protocol was dangerous during the pandemic.
The Right to Life League applauds this decision.
The Food and Drug Administration placed certain rules on administering the abortion pill in order to protect women’s safety. Mifepristone–one of the two drugs taken to achieve a chemical abortion–is one of only a few drugs that falls under the FDA’s Risk Evaluation and Mitigation System (REMS), requiring that it be dispensed only in clinics, medical offices, hospitals, or under the supervision of a certified prescriber.
These protocols are in place to preserve women’s safety.
Yet the pro-abortion movement claims that removing these protocols is better for women.
Julia Kaye, staff attorney at the American Civil Liberties Union Reproductive Freedom Project, was quoted as saying the court’s decision “needlessly” endangers “even more people during this dark pandemic winter.”
It is the ultimate irony that anyone would claim that removing REMS requirements threatens women’s safety… because it makes it easier for them to obtain a dangerous drug that could harm them, and will work to kill their unborn children.
January 22 is coming up fast. This is the day the pro-abortion lobby celebrates the Supreme Courts Roe v. Wade decision.
It also happens to be National Sanctity of Human Life Day. As we prepare to celebrate that particular observance, let us give great thanks for this Supreme Court decision–for the lives of the women and children it will save.